Abstract

IRBVolume 40, Issue 1 p. 18-20 COMMENTARY The Food and Drug Administration’s Federal Review of a Pediatric Muscular Dystrophy Protocol Donna L. Snyder MD, Donna L. Snyder MD pediatric ethics team lead and a pediatric ethicist U.S. Food and Drug Administration, Office of Pediatric Therapeutics in the Office of the Commissioner Snyder DL, Nelson RM. The Food and Drug Administration’s federal review of a pediatric muscular dystrophy protocol. IRB: Ethics & Human Research 2018;40(1):18-20.Search for more papers by this authorRobert M. Nelson MD, PhD, Robert M. Nelson MD, PhD deputy director of and a senior pediatric ethicist U.S. Food and Drug Administration, Office of Pediatric Therapeutics in the Office of the CommissionerSearch for more papers by this author Donna L. Snyder MD, Donna L. Snyder MD pediatric ethics team lead and a pediatric ethicist U.S. Food and Drug Administration, Office of Pediatric Therapeutics in the Office of the Commissioner Snyder DL, Nelson RM. The Food and Drug Administration’s federal review of a pediatric muscular dystrophy protocol. IRB: Ethics & Human Research 2018;40(1):18-20.Search for more papers by this authorRobert M. Nelson MD, PhD, Robert M. Nelson MD, PhD deputy director of and a senior pediatric ethicist U.S. Food and Drug Administration, Office of Pediatric Therapeutics in the Office of the CommissionerSearch for more papers by this author First published: 01 January 2018 https://doi.org/10.1002/eahr.401003Citations: 1 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume40, Issue1January-February 2018Pages 18-20 RelatedInformation

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.